This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Alisha Creel
Associate Vice President
Contact
AlishaCreel@westat.comOverview
Alisha Creel, PhD, is an Associate Vice President for Survey Management and Design. She provides project management and financial oversight for Westat’s premier in-person surveys and contributes expertise on study design and instrument development, cognitive testing, data collection and management, and data analysis and dissemination to various audiences.
Earlier in her career, Creel provided financial and management oversight for a health survey practice. She has directed telephone, mail, and web surveys; program evaluations; and qualitative research. Creel’s wide-ranging topical interests include health services research, military and veteran health, problematic alcohol use, prescription drug misuse, health-related stigma and interventions to reduce stigma, barriers to care and screening, and sexual assault prevention.
Education
- PhD, Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health
- BA, Psychology, Harvard University
-
Author response to e-cigarettes and respiratory disorder: The broader research context
Nicotine and Tobacco Research
January 2023
J.D. Sargent, K.C. Edwards, J. Emond, S. Tanski, Kristie Taylor, J.P. Pierce, M.L. Goniewicz, et al.
DOILink for: Author response to e-cigarettes and respiratory disorder: The broader research context -
Smokeless tobacco use and prevalence of cardiovascular disease among males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1–4
25,
Preventive Medicine Reports
January 2022
G.J. Nahhas, K.M. Cummings, M.J. Halenar, E. Sharma, A.J. Alberg, D. Hatuskami, M. Bansal-Travers, et al.
DOILink for: Smokeless tobacco use and prevalence of cardiovascular disease among males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1–4 -
Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study indicators of tobacco dependence using biomarkers of nicotine exposure across tobacco products
24,
Nicotine and Tobacco Research
January 2022
D.R. Strong, E. Leas, M. Noble, M. White, A. Glasser, Kristie Taylor, K.C. Edwards, et al.
DOILink for: Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study indicators of tobacco dependence using biomarkers of nicotine exposure across tobacco products